Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Sodium"" wg kryterium: Temat


Starter badań:

Tytuł:
Inhibition of Sodium-Glucose Cotransporter-2 during Serum Deprivation Increases Hepatic Gluconeogenesis via the AMPK/AKT/FOXO Signaling Pathway.
Autorzy:
Lee J; Institute of Medical Research, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Hong SW; Institute of Medical Research, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim MJ; Institute of Medical Research, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lim YM; Institute of Medical Research, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Moon SJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kwon H; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Park SE; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Rhee EJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee WY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2024 Feb; Vol. 39 (1), pp. 98-108. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/pharmacology
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Humans ; AMP-Activated Protein Kinases/metabolism ; Gluconeogenesis/genetics ; Glucose ; Phosphoenolpyruvate Carboxykinase (ATP)/genetics ; Phosphoenolpyruvate Carboxykinase (ATP)/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Proto-Oncogene Proteins c-akt/pharmacology ; Proto-Oncogene Proteins c-akt/therapeutic use ; RNA, Small Interfering/genetics ; RNA, Small Interfering/metabolism ; RNA, Small Interfering/pharmacology ; Signal Transduction ; Sodium/metabolism ; Sodium/pharmacology ; Sodium/therapeutic use ; Sodium-Glucose Transporter 2/metabolism ; Sodium-Glucose Transporter 2/pharmacology ; Sodium-Glucose Transporter 2/therapeutic use
Czasopismo naukowe
Tytuł:
Adequate iodine nutrition and higher salt intake in Chinese adults aged 18-59 years recommended by international organizations.
Autorzy:
Chen D; Institute for Endemic and Chronic Non-Communicable Diseases, Fujian Center for Disease Control and Prevention, Fuzhou, 350012, Fujian, China.; School of Public Health, Fujian Medical University, Fuzhou, 350122, Fujian, China.
Ye Y; Institute for Endemic and Chronic Non-Communicable Diseases, Fujian Center for Disease Control and Prevention, Fuzhou, 350012, Fujian, China.; School of Public Health, Fujian Medical University, Fuzhou, 350122, Fujian, China.
Lan Y; Institute for Endemic and Chronic Non-Communicable Diseases, Fujian Center for Disease Control and Prevention, Fuzhou, 350012, Fujian, China.
He M; Institute for Endemic and Chronic Non-Communicable Diseases, Fujian Center for Disease Control and Prevention, Fuzhou, 350012, Fujian, China.
Wu J; Institute for Endemic and Chronic Non-Communicable Diseases, Fujian Center for Disease Control and Prevention, Fuzhou, 350012, Fujian, China.
Wang L; Institute for Endemic and Chronic Non-Communicable Diseases, Fujian Center for Disease Control and Prevention, Fuzhou, 350012, Fujian, China.
Chen Z; Institute for Endemic and Chronic Non-Communicable Diseases, Fujian Center for Disease Control and Prevention, Fuzhou, 350012, Fujian, China. .; School of Public Health, Fujian Medical University, Fuzhou, 350122, Fujian, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 24; Vol. 14 (1), pp. 6993. Date of Electronic Publication: 2024 Mar 24.
Typ publikacji:
Journal Article
MeSH Terms:
Iodine*/urine
Sodium Chloride, Dietary*/adverse effects
Sodium Chloride, Dietary*/analysis
Adolescent ; Adult ; Female ; Humans ; Male ; Middle Aged ; Young Adult ; China ; Nutritional Status ; Sodium/urine
Czasopismo naukowe
Tytuł:
Positive association between sodium-to-chloride ratio and in-hospital mortality of acute heart failure.
Autorzy:
Wei D; Department of Cardiovascular, Liuzhou Traditional Chinese Medical Hospital, Liuzhou, 545001, China. .
Chen S; Guangxi University of Chinese Medicine, Nanning, 530000, China.
Xiao D; Guangxi University of Chinese Medicine, Nanning, 530000, China.
Chen R; Guangxi University of Chinese Medicine, Nanning, 530000, China.
Meng Y; Guangxi University of Chinese Medicine, Nanning, 530000, China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 03; Vol. 14 (1), pp. 7846. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:
Journal Article
MeSH Terms:
Sodium Chloride*
Heart Failure*
Humans ; Chlorides ; Hospital Mortality ; Critical Illness ; Prognosis ; Sodium ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies.
Autorzy:
Gan L; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University; Xiangya School of Public Health, Central South University; CSU-Sinocare Research Center for Nutrition and Metabolic Health; Furong Laboratory, Changsha, Hunan, 410011, China.
Zhao B; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University; Xiangya School of Public Health, Central South University; CSU-Sinocare Research Center for Nutrition and Metabolic Health; Furong Laboratory, Changsha, Hunan, 410011, China.
Inoue-Choi M; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA.
Liao LM; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA.
Graubard BI; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA.
Weinstein SJ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA.
Albanes D; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA. .
Huang J; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University; Xiangya School of Public Health, Central South University; CSU-Sinocare Research Center for Nutrition and Metabolic Health; Furong Laboratory, Changsha, Hunan, 410011, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Mar 22; Vol. 22 (1), pp. 132. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Cardiovascular Diseases*
Sodium, Dietary*/adverse effects
Adult ; Female ; Humans ; Male ; Cohort Studies ; Sodium ; Cause of Death ; Prospective Studies ; Diet ; Risk Factors ; Potassium
Czasopismo naukowe
Tytuł:
The dispensability of 14-3-3 proteins for the regulation of human cardiac sodium channel Nav1.5.
Autorzy:
Iamshanova O; Faculty of Medicine, Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Hämmerli AF; Faculty of Medicine, Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Ramaye E; Faculty of Medicine, Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Seljmani A; Faculty of Medicine, Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.; medi-Center for Medical Education, Bern, Switzerland.
Ross-Kaschitza D; Faculty of Medicine, Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Schärz N; Faculty of Medicine, Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.; medi-Center for Medical Education, Bern, Switzerland.
Essers M; Faculty of Medicine, Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Guichard S; Faculty of Medicine, Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Rougier JS; Faculty of Medicine, Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Abriel H; Faculty of Medicine, Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0298820. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
14-3-3 Proteins*/genetics
14-3-3 Proteins*/metabolism
Voltage-Gated Sodium Channels*/metabolism
Humans ; Myocytes, Cardiac/metabolism ; Cell Line ; Arrhythmias, Cardiac ; NAV1.5 Voltage-Gated Sodium Channel/genetics ; NAV1.5 Voltage-Gated Sodium Channel/metabolism
Czasopismo naukowe
Tytuł:
Abrupt Decline in Estimated Glomerular Filtration Rate after Initiating Sodium-Glucose Cotransporter 2 Inhibitors Predicts Clinical Outcomes: A Systematic Review and Meta-Analysis.
Autorzy:
Chuang MH; Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
Tang YS; Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.; Taipei Medical University Research Center of Urology and Kidney, Taipei, Taiwan.
Chen JY; Division of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.; Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.
Pan HC; Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
Liao HW; Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.; Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Chu WK; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Cheng CY; Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.; Taipei Medical University Research Center of Urology and Kidney, Taipei, Taiwan.; Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Wu VC; Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Heung M; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
Pokaż więcej
Źródło:
Diabetes & metabolism journal [Diabetes Metab J] 2024 Mar; Vol. 48 (2), pp. 242-252. Date of Electronic Publication: 2024 Jan 26.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Cardiovascular Diseases*/etiology
Heart Failure*
Humans ; Glomerular Filtration Rate ; Glucose/pharmacology ; Sodium/pharmacology
Czasopismo naukowe
Tytuł:
Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial).
Autorzy:
Al-Ozairi E; Dasman Diabetes Institute, Kuwait City, Kuwait.
Narula K; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. .
Miras AD; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; School of Medicine, Ulster University, Coleraine, UK.
Taghadom E; Dasman Diabetes Institute, Kuwait City, Kuwait.; Amiri Hospital, Ministry of Health, Kuwait City, Kuwait.
Samad AE; Dasman Diabetes Institute, Kuwait City, Kuwait.
Al Kandari J; Dasman Diabetes Institute, Kuwait City, Kuwait.; Amiri Hospital, Ministry of Health, Kuwait City, Kuwait.
Alyosef A; Amiri Hospital, Ministry of Health, Kuwait City, Kuwait.
Mashankar A; Dasman Diabetes Institute, Kuwait City, Kuwait.
Al-Najim W; School of Medicine, Ulster University, Coleraine, UK.; Diabetes Complications Research Centre, Conway Institute, University College of Dublin, Dublin, Ireland.
le Roux CW; School of Medicine, Ulster University, Coleraine, UK.; Diabetes Complications Research Centre, Conway Institute, University College of Dublin, Dublin, Ireland.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Feb 16; Vol. 25 (1), pp. 129. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 1*/diagnosis
Diabetes Mellitus, Type 1*/drug therapy
Diabetes Mellitus, Type 1*/complications
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Renal Insufficiency, Chronic*/diagnosis
Renal Insufficiency, Chronic*/drug therapy
Renal Insufficiency, Chronic*/complications
Humans ; Young Adult ; Adult ; Middle Aged ; Aged ; Hypoglycemic Agents/adverse effects ; Glucagon-Like Peptide 1 ; Obesity/complications ; Obesity/diagnosis ; Obesity/drug therapy ; Glucose ; Sodium ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Risks and Benefits of SGLT-2 Inhibitors for Type 1 Diabetes Patients Using Automated Insulin Delivery Systems-A Literature Review.
Autorzy:
Elian V; Department of Diabetes, Nutrition and Metabolic Diseases, 'Carol Davila' University of Medicine and Pharmacy, 5-7 Ion Movila Street, 020475 Bucharest, Romania.; Department of Diabetes, Nutrition and Metabolic Diseases, 'N. C. Paulescu' National Institute of Diabetes, Nutrition and Metabolic Diseases, 020475 Bucharest, Romania.
Popovici V; 'Costin C. Kiriţescu' National Institute of Economic Research-Center for Mountain Economics (INCE-CEMONT) of Romanian Academy, 725700 Vatra-Dornei, Romania.
Karampelas O; Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, 'Carol Davila' University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania.
Pircalabioru GG; eBio-Hub Research Centre, National University of Science and Technology Politehnica Bucharest, 061344 Bucharest, Romania.; Research Institute, University of Bucharest, 061344 Bucharest, Romania.; Academy of Romanian Scientists, 54 Splaiul Independentei, 050094 Bucharest, Romania.
Radulian G; Department of Diabetes, Nutrition and Metabolic Diseases, 'Carol Davila' University of Medicine and Pharmacy, 5-7 Ion Movila Street, 020475 Bucharest, Romania.; Department of Diabetes, Nutrition and Metabolic Diseases, 'N. C. Paulescu' National Institute of Diabetes, Nutrition and Metabolic Diseases, 020475 Bucharest, Romania.
Musat M; eBio-Hub Research Centre, National University of Science and Technology Politehnica Bucharest, 061344 Bucharest, Romania.; Department of Endocrinology, 'Carol Davila' University of Medicine and Pharmacy, 030167 Bucharest, Romania.; Department of Endocrinology IV, 'C. I. Parhon' National Institute of Endocrinology, 011863 Bucharest, Romania.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 06; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetes Mellitus, Type 1*/drug therapy
Insulin*/therapeutic use
Sodium-Glucose Transporter 2 Inhibitors*/pharmacology
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Humans ; Dipeptidyl-Peptidase IV Inhibitors/therapeutic use ; Glucose/therapeutic use ; Hypoglycemic Agents/adverse effects ; Multicenter Studies as Topic ; Risk Assessment ; Sodium
Czasopismo naukowe
Tytuł:
Impact on backpropagation of the spatial heterogeneity of sodium channel kinetics in the axon initial segment.
Autorzy:
Barlow BSM; Department of Physics, University of Ottawa, STEM Complex, 150 Louis-Pasteur Pvt, Ottawa, Ontario, Canada.
Longtin A; Department of Physics, University of Ottawa, STEM Complex, 150 Louis-Pasteur Pvt, Ottawa, Ontario, Canada.; Center for Neural Dynamics and AI, University of Ottawa, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Joós B; Department of Physics, University of Ottawa, STEM Complex, 150 Louis-Pasteur Pvt, Ottawa, Ontario, Canada.; Center for Neural Dynamics and AI, University of Ottawa, Ottawa, Ontario, Canada.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2024 Mar 15; Vol. 20 (3), pp. e1011846. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Axon Initial Segment*/physiology
Voltage-Gated Sodium Channels*
NAV1.6 Voltage-Gated Sodium Channel/ultrastructure ; Axons/physiology ; Neurons/physiology ; Action Potentials/physiology
Czasopismo naukowe
Tytuł:
Does Treatment with Sodium-Glucose Cotransporter-2 Inhibitors Affect Adherence to International Society Criteria for Diabetic Ketoacidosis in Adult Patients with Type 2 Diabetes? A Retrospective Cohort Analysis.
Autorzy:
O'Brolchain A; Department of Medicine, Gold Coast Health, Gold Coast, Queensland, Australia.; Griffith University, Queensland, Australia.
Maletsky J; Department of Medicine, Gold Coast Health, Gold Coast, Queensland, Australia.
Mian I; Department of Medicine, Gold Coast Health, Gold Coast, Queensland, Australia.
Edwards S; Department of Medicine, Gold Coast Health, Gold Coast, Queensland, Australia.
Pokaż więcej
Źródło:
Journal of diabetes research [J Diabetes Res] 2024 Mar 14; Vol. 2024, pp. 1849522. Date of Electronic Publication: 2024 Mar 14 (Print Publication: 2024).
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/chemically induced
Diabetic Ketoacidosis*/diagnosis
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Adult ; Humans ; United States ; Adolescent ; Retrospective Studies ; Cohort Studies ; Glucose ; Sodium
Czasopismo naukowe
Tytuł:
The Role of Sodium-Glucose Co-Transporter-2 Inhibitors on Diuretic Resistance in Heart Failure.
Autorzy:
Stachteas P; Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
Nasoufidou A; Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
Patoulias D; Outpatient Department of Cardiometabolic Medicine, Second Department of Cardiology, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
Karakasis P; Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
Karagiannidis E; Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
Mourtzos MA; Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
Samaras A; Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
Apostolidou X; Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
Fragakis N; Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.; Outpatient Department of Cardiometabolic Medicine, Second Department of Cardiology, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 08; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Heart Failure*/complications
Symporters*
Diabetes Mellitus, Type 2*/drug therapy
Humans ; Diuretics/adverse effects ; Glucose/therapeutic use ; Sodium
Czasopismo naukowe
Tytuł:
Polyelectrolyte Microcapsules: An Extended Release System for the Antiarrhythmic Complex of Allapinin with Glycyrrhizic Acid Salt.
Autorzy:
Salikhov SI; Institute of Bioorganic Chemistry Named after A.Sadykov Academy of Sciences of the Republic of Uzbekistan, M. Ulugbek Str., 83, Tashkent 100125, Uzbekistan.
Musin EV; Institute of Theoretical and Experimental Biophysics Russian Academy of Science, Institutskaya St., 3, 142290 Puschino, Moscow Region, Russia.
Kim AL; Institute of Theoretical and Experimental Biophysics Russian Academy of Science, Institutskaya St., 3, 142290 Puschino, Moscow Region, Russia.
Oshchepkova YI; Institute of Bioorganic Chemistry Named after A.Sadykov Academy of Sciences of the Republic of Uzbekistan, M. Ulugbek Str., 83, Tashkent 100125, Uzbekistan.
Tikhonenko SA; Institute of Theoretical and Experimental Biophysics Russian Academy of Science, Institutskaya St., 3, 142290 Puschino, Moscow Region, Russia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 24; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Glycyrrhizic Acid*
Sodium Chloride*
Aconitine/*analogs & derivatives
Polyelectrolytes ; Capsules/chemistry ; Sodium Chloride, Dietary
Czasopismo naukowe
Tytuł:
Validation of spot urine in estimating 24-h urinary sodium, potassium and sodium-to-potassium ratio during three different sodium diets in healthy adults.
Autorzy:
Groenland EH; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Vendeville JAC; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Bots ML; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Visseren FLJ; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Musson REA; Department of Clinical Chemistry and Haematology, University Medical Centre Utrecht, Utrecht, the Netherlands.
Spiering W; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Pokaż więcej
Źródło:
Blood pressure [Blood Press] 2023 Dec; Vol. 32 (1), pp. 2170868.
Typ publikacji:
Journal Article
MeSH Terms:
Sodium Chloride, Dietary*
Sodium, Dietary*/urine
Humans ; Adult ; Potassium/urine ; Sodium/urine ; Diet
Czasopismo naukowe
Tytuł:
Utilization of Yeast Extract as a Flavor Enhancer and Masking Agent in Sodium-Reduced Marinated Shrimp.
Autorzy:
Şen Yılmaz EB; Faculty of Fisheries, Ege University, 35100 Bornova, Izmir, Turkey.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Dec 28; Vol. 29 (1). Date of Electronic Publication: 2023 Dec 28.
Typ publikacji:
Journal Article
MeSH Terms:
Sodium*
Penaeidae*
Humans ; Animals ; Sodium Chloride ; Flavoring Agents ; Saccharomyces cerevisiae ; Seafood ; Amino Acids ; Sodium Chloride, Dietary
Czasopismo naukowe
Tytuł:
The associations of self-reported salt-intake and spot urine sodium with home blood pressure.
Autorzy:
Wistrand H; Division of Medicine, University of Turku, Turku, Finland.
Niiranen T; Division of Medicine, Turku University Hospital and University of Turku, Turku, Finland.; Finnish Institute for Health and Welfare, Helsinki, Finland.
Kaartinen NE; Finnish Institute for Health and Welfare, Helsinki, Finland.
Langén VL; Division of Medicine, Turku University Hospital and University of Turku, Turku, Finland.; Department of Geriatric Medicine, Turku University Hospital and University of Turku, Turku, Finland.
Pokaż więcej
Źródło:
Blood pressure [Blood Press] 2023 Dec; Vol. 32 (1), pp. 2203267.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension*/epidemiology
Sodium, Dietary*
Humans ; Sodium ; Blood Pressure/physiology ; Sodium Chloride, Dietary/adverse effects ; Self Report ; Cross-Sectional Studies
Czasopismo naukowe
Tytuł:
Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a narrative review.
Autorzy:
Mentz RJ; Division of Cardiology, Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, 40 Duke Medicine Circle, Durham, NC, 27710, USA. .
Brunton SA; Primary Care Metabolic Group, Winnsboro, SC, USA.
Rangaswami J; Division of Nephrology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Nov 16; Vol. 22 (1), pp. 316. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:
Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Heart Failure*/diagnosis
Heart Failure*/drug therapy
Heart Failure*/epidemiology
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Renal Insufficiency, Chronic*/diagnosis
Renal Insufficiency, Chronic*/drug therapy
Renal Insufficiency, Chronic*/epidemiology
Humans ; Stroke Volume ; Sodium-Glucose Transporter 2 ; Ventricular Function, Left ; Glucose ; Sodium
Czasopismo naukowe
Tytuł:
Associations between estimation of salt intake and salt-restriction spoons and hypertension status in patients with poorly controlled hypertension: a community-based study from Huzhou City, Eastern China.
Autorzy:
Zhang Q; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang Province, China.
Shen Y; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang Province, China. yimei_.
Yu M; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang Province, China.
Yang Z; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang Province, China.
Huang Z; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang Province, China.
Ding J; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang Province, China.
Zhu X; Huzhou Center for Disease Control and Prevention, Huzhou, Zhejiang Province, China.
Pokaż więcej
Źródło:
Nutrition journal [Nutr J] 2024 Jan 15; Vol. 23 (1), pp. 9. Date of Electronic Publication: 2024 Jan 15.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension*/epidemiology
Sodium, Dietary*
Humans ; Sodium Chloride, Dietary/urine ; Sodium/urine ; China/epidemiology
Czasopismo naukowe
Tytuł:
Intake and food sources of sodium in the population residing in urban areas of Ecuador: results from ELANS study.
Autorzy:
Villar M; Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Quito, Ecuador.
García MCY; Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Quito, Ecuador.
Ocampo MB; Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Quito, Ecuador.
Gómez G; Department of Biochemistry, School of Medicine, Universidad de Costa Rica, San José, Costa Rica.
Pokaż więcej
Źródło:
Global health action [Glob Health Action] 2023 Dec 31; Vol. 16 (1), pp. 2156110.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Sodium*
Food*
Male ; Female ; Humans ; Ecuador ; Feeding Behavior ; Sodium Chloride, Dietary ; Urban Population
Czasopismo naukowe
Tytuł:
The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials.
Autorzy:
Gohari S; Student Research Center, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Ismail-Beigi F; Department of Medicine, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Mahjani M; Endocrine Research Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Ghobadi S; Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences, Deakin University, Melbourne, VIC, Australia.
Jafari A; Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Ahangar H; Department of Cardiology, School of Medicine, Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
Gohari S; Department of Systems Science and Industrial Engineering, State University of New York at Binghamton, Binghamton, NY, USA.
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2023 Nov 24; Vol. 23 (1), pp. 257. Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Diabetes Mellitus, Type 2*/complications
Humans ; Hypoglycemic Agents/therapeutic use ; Interleukin-6 ; Sodium-Glucose Transporter 2/therapeutic use ; Randomized Controlled Trials as Topic ; Glucose ; Sodium
Czasopismo naukowe
Tytuł:
A low dietary sodium dose is associated with a more pronounced aldosterone response in normotensive than in hypertensive individuals.
Autorzy:
Graudal N; Center for Rheumatology and Spine Diseases, The Lupus and Vasculitis Clinic 4242, Copenhagen University Hospital Rigshospitalet, Juliane Maries Vej 10, Copenhagen, Denmark. .
Hubeck-Graudal T; Department of Nuclear Medicine, Zealand University Hospital, Næstved, Ringstedgade 61, 4700, Næstved, Denmark.
Jurgens G; Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Sygehusvej 10, 4000, Roskilde, Denmark.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 03; Vol. 13 (1), pp. 19027. Date of Electronic Publication: 2023 Nov 03.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Hypertension*
Sodium, Dietary*
Humans ; Aldosterone ; Blood Pressure/physiology ; Sodium ; Sodium Chloride, Dietary ; Randomized Controlled Trials as Topic
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies